Search Within

Alexander Edward Drilon

  1. "Center for Molecular Imaging and Biotechnology"
Formats
  1. Journal Article (9)
  2. Meeting Abstract (9)
  3. Book Section (1)
Groups
  1. Center for Molecular Imaging and Biotechnology (19)
  2. Department of Medicine (19)
  3. GSK Faculty (19)
  4. Solid Tumor Oncology Division (19)
  5. Thoracic Oncology (19)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (16)

More Groups

People
  1. Charles Rudin (15)
  2. Mark Kris (8)
  3. Marc Ladanyi (7)
  4. Gregory Riely (6)
  5. Romel Somwar (6)
  6. Natasha Rekhtman (5)

More People

Years
  1. 2024 (1)
  2. 2023 (2)
  3. 2022 (2)
  4. 2019 (1)
  5. 2018 (2)
  6. 2017 (2)

More Years

Publications
  1. Journal of Thoracic Oncology (5)
  2. Journal of Clinical Oncology (4)
  3. European Journal of Cancer (2)
  4. Cancer Discovery (1)
  5. JCO Precision Oncology (1)
  6. Journal for ImmunoTherapy of Cancer (1)

More Publications

Publishers
  1. Elsevier Inc. (7)
  2. American Society of Clinical Oncology (5)
  3. Nature Publishing Group (2)
  4. American Association for Cancer Research (1)
  5. Biomed Central Ltd (1)
  6. Elsevier Ireland Ltd. (1)

More Publishers

Results (19)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Lung neuroendocrine neoplasms harboring ALK, RET and other receptor tyrosine kinase fusions: Spectrum of pathologic features from conventional neuroendocrine carcinomas to unusual carcinoid-type tumors with focal mucin or adenocarcinoma components
    Meeting Abstract

    Armstrong, S.; Chang, J.; Yang, S. R.; Samuel, T.; Hussain, S.; Velez, M.; Baine, M.; Travis, W.; Drilon, A.; Quintanal-Villalonga, A.; more...
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • Microsatellite instability defines a subset of lung cancers with smoking exposure, high tumor mutational burden and MLH1 inactivation
    Meeting Abstract

    Yang, S. R.; Gedvilaite, E.; Ptashkin, R.; Chang, J.; Ziegler, J.; Mata, D.; Villafania, L. B.; Nafa, K.; Hechtman, J. F.; Benhamida, J.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Combination therapy with MDM2 and MEK inhibitors is effective in patient-derived models of lung adenocarcinoma with concurrent oncogenic drivers and MDM2 amplification
    Journal Article

    Elkrief, A.; Odintsov, I.; Markov, V.; Caeser, R.; Sobczuk, P.; Tischfield, S. E.; Bhanot, U.; Vanderbilt, C. M.; Cheng, E. H.; Drilon, A.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Selpercatinib-induced hypothyroidism through off-target inhibition of type 2 iodothyronine deiodinase
    Journal Article

    Boucai, L.; Salas-Lucia, F.; Krishnamoorthy, G. P.; Sherman, E.; Rudin, C. M.; Drilon, A.; Bianco, A. C.; Fagin, J. A.
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Immunogenic landscape and therapeutic targeting of mutant NRAS "public" neoantigens
    Meeting Abstract

    Etxeberria, I.; Banks, L.; Chandran, S.; Correa, A.; Novak, B.; Fleischman, J.; Drilon, A.; Wolchok, J.; Merghoub, T.; Klebanoff, C.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Afatinib in patients with metastatic or recurrent HER2-mutant lung cancers: A retrospective international multicentre study
    Journal Article

    Lai, W. V.; Lebas, L.; Barnes, T. A.; Milia, J.; Ni, A.; Gautschi, O.; Peters, S.; Ferrara, R.; Plodkowski, A. J.; Kavanagh, J.; more...
    European Journal of Cancer (2019)

    Fulltext@MSK | Save
  • Outcomes of advanced pulmonary large cell neuroendocrine carcinoma stratified by RB1 loss, SLFN11 expression, and tumor mutational burden
    Meeting Abstract

    Sabari, J. K.; Julian, R. A.; Ni, A.; Halpenny, D.; Hellmann, M. D.; Drilon, A. E.; Li, B. T.; Poirier, J. T.; Rudin, C. M.; Rekhtman, N.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Response to ERBB3-directed targeted therapy in NRG1-rearranged cancers
    Journal Article

    Drilon, A.; Somwar, R.; Mangatt, B. P.; Edgren, H.; Desmeules, P.; Ruusulehto, A.; Smith, R. S.; Delasos, L.; Vojnic, M.; Plodkowski, A. J.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • A phase 2 study of cabozantinib for patients with advanced RET-rearranged lung cancers
    Meeting Abstract

    Drilon, A.; Somwar, R.; Smith, R.; Delasos, L.; Albano, M.; Van Voorthuyson, M.; Wang, L.; Rekhtman, N.; Ni, A.; Plodkowski, A.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target
    Journal Article

    Cook, P. J.; Thomas, R.; Kannan, R.; de Leon, E. S.; Drilon, A.; Rosenblum, M. K.; Scaltriti, M.; Benezra, R.; Ventura, A.
    Nature Communications (2017)

    Fulltext@MSK | Save